Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Kubicka

Showing results (51-60 of 67) with videos related to

Pageof 7
Sort By:
Gut|August 13, 2003
Telomere shortening of epithelial cells characterises the adenoma-carcinoma transition of human colorectal cancerR R Plentz, S U Wiemann, P Flemming, et al.
British Journal of Cancer|May 5, 2005
Survival rate in patients with hepatocellular carcinoma: a retrospective analysis of 389 patientsT F Greten, F Papendorf, J S Bleck, et al.
Journal of Hepatology|March 6, 1999
Familial Amyloidotic Polyneuropathy: domino liver transplantationH H Schmidt, B Nashan, M J Pröpsting, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 2, 2010
Cetuximab with irinotecan, folinic acid and 5-fluorouracil as first-line treatment in advanced gastroesophageal cancer: a prospective multi-center biomarker-oriented phase II studyM Moehler, A Mueller, T Trarbach, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 22, 2001
Dissection of the intracellular pathways in hepatocytes suggests a role for Jun kinase and IFN regulatory factor-1 in Con A-induced liver failureK Streetz, B Fregien, J Plümpe, et al.
Hepatology (Baltimore, Md.)|September 1, 1996
Hepatitis B virus mutations in the pre-S genome before and after liver transplantationC Trautwein, H Schrem, H L Tillmann, et al.
Journal of Hepatology|January 6, 1999
Arterial chemoembolization before liver transplantation in patients with hepatocellular carcinoma: marked tumor necrosis, but no survival benefit?K J Oldhafer, A Chavan, N R Frühauf, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 24, 2005
Chemoocclusion vs chemoperfusion for treatment of advanced hepatocellular carcinoma: a randomised trialT D Kirchhoff, K L Rudolph, G Layer, et al.
Gut|April 17, 2001
Low frequency of HLA-DRB1*11 in hepatitis C virus induced end stage liver diseaseH L Tillmann, D F Chen, C Trautwein, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 16, 2013
Bevacizumab plus chemotherapy continued beyond first progression in patients with metastatic colorectal cancer previously treated with bevacizumab plus chemotherapy: ML18147 study KRAS subgroup findingsS Kubicka, R Greil, T André, et al.
Pageof 7

Showing results (51-60 of 67) with videos related to

Sort By:
Pageof 7
Gut|August 13, 2003
Telomere shortening of epithelial cells characterises the adenoma-carcinoma transition of human colorectal cancerR R Plentz, S U Wiemann, P Flemming, et al.
British Journal of Cancer|May 5, 2005
Survival rate in patients with hepatocellular carcinoma: a retrospective analysis of 389 patientsT F Greten, F Papendorf, J S Bleck, et al.
Journal of Hepatology|March 6, 1999
Familial Amyloidotic Polyneuropathy: domino liver transplantationH H Schmidt, B Nashan, M J Pröpsting, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 2, 2010
Cetuximab with irinotecan, folinic acid and 5-fluorouracil as first-line treatment in advanced gastroesophageal cancer: a prospective multi-center biomarker-oriented phase II studyM Moehler, A Mueller, T Trarbach, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 22, 2001
Dissection of the intracellular pathways in hepatocytes suggests a role for Jun kinase and IFN regulatory factor-1 in Con A-induced liver failureK Streetz, B Fregien, J Plümpe, et al.
Hepatology (Baltimore, Md.)|September 1, 1996
Hepatitis B virus mutations in the pre-S genome before and after liver transplantationC Trautwein, H Schrem, H L Tillmann, et al.
Journal of Hepatology|January 6, 1999
Arterial chemoembolization before liver transplantation in patients with hepatocellular carcinoma: marked tumor necrosis, but no survival benefit?K J Oldhafer, A Chavan, N R Frühauf, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 24, 2005
Chemoocclusion vs chemoperfusion for treatment of advanced hepatocellular carcinoma: a randomised trialT D Kirchhoff, K L Rudolph, G Layer, et al.
Gut|April 17, 2001
Low frequency of HLA-DRB1*11 in hepatitis C virus induced end stage liver diseaseH L Tillmann, D F Chen, C Trautwein, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 16, 2013
Bevacizumab plus chemotherapy continued beyond first progression in patients with metastatic colorectal cancer previously treated with bevacizumab plus chemotherapy: ML18147 study KRAS subgroup findingsS Kubicka, R Greil, T André, et al.
Pageof 7